Provided by Tiger Trade Technology Pte. Ltd.

CASI Pharmaceuticals

0.9247
-0.0253-2.66%
Post-market: 0.92470.00000.00%16:10 EST
Volume:17.36K
Turnover:16.21K
Market Cap:19.00M
PE:-0.31
High:0.9500
Open:0.9237
Low:0.9050
Close:0.9500
52wk High:3.09
52wk Low:0.7500
Shares:20.55M
Float Shares:9.33M
Volume Ratio:0.82
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9845
EPS(LYR):-2.5591
ROE:-1094.50%
ROA:-61.80%
PB:-0.66
PE(LYR):-0.36

Loading ...

CASI Pharmaceuticals Fails to Renew FOLOTYN Import License in China, Halts Sales

TIPRANKS
·
Jan 22

CASI Pharmaceuticals Inc: Failure to Renew Import Drug Registration License for Folotyn in China

THOMSON REUTERS
·
Jan 22

CASI Pharmaceuticals Receives China NMPA Approval for Phase 1/2 Clinical Trial of CID-103 in Renal Allograft AMR

Reuters
·
Jan 15

CASI Pharmaceuticals Reports 80% Efficacy in Phase 1 Study of CID-103 for Immune Thrombocytopenia

Reuters
·
Jan 12

Wei-Wu He - Proposed to Acquire Through Acquisition Vehicle All of Publicly Held CASI Pharmaceuticals Shares for US$1.15 per Share in Cash

THOMSON REUTERS
·
Jan 09

Wei-Wu He - on Jan 9 Submitted Updated Preliminary Non-Binding Proposal Letter to CASI Pharmaceuticals' Board -SEC Filing

THOMSON REUTERS
·
Jan 09

Wei-Wu He - Will Not Consider Any Pipe Financing Transaction as an Alternative

THOMSON REUTERS
·
Jan 09

Wei-Wu He - Intends to Finance the Transactions Contemplated by Proposal Through Combination of Debt and Equity

THOMSON REUTERS
·
Jan 09

CASI Pharmaceuticals Faces Nasdaq Delisting Risk Pending Compliance with Listing Standards

Reuters
·
Dec 24, 2025

Sprinkles (HK) Charity Foundation Donates to The Education University of Hong Kong to Promote "Harmony between Humanity and Nature Sustainable Education" Project

prnewswire
·
Dec 23, 2025

CASI Academy Launches Sustainable Investing Program for Hong Kong's MPF Industry

prnewswire
·
Dec 18, 2025

CASI Pharmaceuticals Inc - Investment to Fund Phase 1 Study in Renal Allograft Antibody-Mediated Rejection (Amr) in China

THOMSON REUTERS
·
Dec 11, 2025

CASI Pharmaceuticals Inc - Announces up to $20 Mln Convertible Note Financing

THOMSON REUTERS
·
Dec 11, 2025

CASI Pharmaceuticals Reports Positive Phase 1 Results for CID-103 in Immune Thrombocytopenia

Reuters
·
Dec 08, 2025

CASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman

Reuters
·
Nov 19, 2025

CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal

TIPRANKS
·
Nov 15, 2025

CASI Pharmaceuticals Q3 EPS $(0.67) Misses $(0.51) Estimate, Sales $3.075M Down From $7.793M YoY

Benzinga
·
Nov 15, 2025

CASI Pharmaceuticals Reports Third Quarter Revenue of $3.1 Million and Net Loss of $10.9 Million

Reuters
·
Nov 15, 2025

North American Morning Briefing: Futures Decline as Investor Caution Rises

Dow Jones
·
Nov 13, 2025

PRI-CASI Sustainability Forum for COP30 concluded in Brazil

prnewswire
·
Nov 12, 2025